Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What CAGR Will the Endocrine Peptide Test Market Achieve During 2025–2034, and What Does It Indicate?
There has been robust growth in the market size of the endocrine peptide test in the last few years. The market is projected to rise from $9.11 billion in 2024 to $9.97 billion in 2025, equivalent to a compound annual growth rate (CAGR) of 9.5%. The significant growth during the past years is attributed to factors like enhanced government spending, an increase in diabetes cases around the world, declining immunity levels in people globally, a heightened risk of developing any chronic diseases, and escalating government initiatives.
Anticipations are high for robust expansion of the endocrine peptide test market in the imminent years. Growth projections estimate the market size to reach $14.22 billion in 2029, with a compound annual growth rate (CAGR) of 9.3%. This progression in the predicted period is associated with the escalating demand for endocrine peptide tests, increased research and development initiatives, a proliferation of lifestyle-related diseases, an aging population, and a rising incidence of diabetes in the general public. Key trends to watch out for during this forecast period include advancements in endocrine testing procedures, technological improvements in products, an increase in R&D to create innovative testing solutions, an uptrend in product approvals, and a shift towards preventive healthcare.
What Key Drivers Are Accelerating the Growth of the Endocrine Peptide Test Market During the Forecast Period?
The escalation in the occurrence of diabetes is anticipated to boost the expansion of the endocrine peptide test market. Diabetes encompasses several illnesses that culminate in elevated blood sugar or glucose levels. The rise of diabetes is driven by various factors such as unwholesome diets, sedentary behavior, inherited predisposition, and an aging populace. The endocrine peptide tests, inclusive of hemoglobin A1c, fasting plasma glucose, and C-peptide tests, are instrumental in diagnosing diabetes, regulating glucose levels, and evaluating insulin production and receptivity. As per the records from the National Health Service (NHS), a government entity in the UK, there was a critical surge in the count of individuals below 40 being diagnosed with diabetes in June 2024, intensifying from 173,166 in 2022 to 216,440 in 2023. This drastic increase points towards a worrisome trend of climbing diabetes prevalence among the younger demographic. Therefore, the escalating occurrence of diabetes is promoting the growth of the endocrine peptide test market.
Get Your Free Sample of the Global Endocrine Peptide Test Market Report Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=16675&type=smp
Who Are the Key Firms Paving the Way for Growth in the Endocrine Peptide Test Market?
Major companies operating in the endocrine peptide test market are:
• Google LLC_x000D_
• Accenture Plc_x000D_
• International Business Machines Corporation_x000D_
• PricewaterhouseCoopers International Limited_x000D_
• Oracle Corporation_x000D_
What Are the Most Influential Trends Currently Shaping the Endocrine Peptide Test Market?
Leading firms in the endocrine peptide test market are creating immunoassay testing systems to increase accuracy, sensitivity, and promptness in endocrine peptide testing. Such systems employ antibodies to identify and quantify specific peptides in blood or urine specimens, delivering crucial data about hormone levels and endocrine function to healthcare practitioners. For example, in July 2023, Siemens Healthineers, a healthcare services organization from Germany, introduced the Atellica CI Analyzer. This compact system is designed for both immunoassay and clinical chemistry testing, which includes endocrine peptide assays. The Analyzer also includes a reproductive endocrinology menu that comprises the anti-Mullerian hormone (AMH), used to ascertain ovarian reserve, and sFlt-1 and PlGF (placental growth factor) for assisting in the prognosis of preeclampsia. The Atellica CI Analyzer is engineered to consistently and quickly produce high-quality outcomes, boasting a capacity of up to 1000 tests per hour. It offers efficiency and adaptability in workflow, enabling labs to address changing testing demands.
Get Instant Access to the Global Endocrine Peptide Test Market Report with Swift Delivery!
https://www.thebusinessresearchcompany.com/report/endocrine-peptide-test-global-market-report
Which Industry Segments Are Leading the Development and Expansion of the Endocrine Peptide Test Market?
The endocrine peptide test market covered in this report is segmented –
1) By Test-Type: Dehydroepiandrosterone Sulphate, Progesterone, Luteinizing Hormone, Thyroid Prolactin, Oestradiol, Human Chorionic Gonadotropin, Thyroid-Stimulating Hormone, Other Test-Types
2) By Technology: Mass Spectroscopy, Immunoassay, Chromatography, Nucleic Acid Based, Other Technologies
3) By End-User: Clinics, Healthcare Centers, Hospitals, Commercial Laboratories
Subsegments:
1) By Dehydroepiandrosterone Sulphate (DHEA-S): Immunoassay Tests, Enzyme-Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA)
2) By Progesterone: Immunoassay Tests, Chemiluminescence Assays, ELISA Tests
3) By Luteinizing Hormone (LH): Immunoassay Tests, Enzyme Immunoassay (EIA), Radioimmunoassay (RIA)
4) By Thyroid Prolactin: Immunoassay Tests, Chemiluminescence Assays, Radioimmunoassay (RIA)
5) By Oestradiol: Immunoassay Tests, Enzyme-Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA)
6) By Human Chorionic Gonadotropin (hCG): Immunoassay Tests, Chemiluminescence Assays, Enzyme Immunoassay (EIA)
7) By Thyroid-Stimulating Hormone (TSH): Immunoassay Tests, Radioimmunoassay (RIA), Enzyme-Linked Immunosorbent Assay (ELISA)
8) Other Test-Types: Cortisol, Insulin, Growth Hormone (GH), Parathyroid Hormone (PTH)
Which Regions Are Essential for the Growth of the Endocrine Peptide Test Market?
North America was the largest region in the endocrine peptide test market in 2024. The regions covered in the endocrine peptide test market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Key Elements Shape the Definition of the Endocrine Peptide Test Market?
Endocrine peptide test refers to a diagnostic test used to measure the levels of specific peptides (small proteins) in the blood or urine that are related to the functioning of the endocrine system. The primary aim of the endocrine peptide test is to diagnose and monitor endocrine disorders by measuring specific peptide hormones in the blood.
Browse Through More Similar Reports By The Business Research Company:
Vital Parameter Monitoring Devices And Equipment Global Market Report 2024
Cardiovascular Monitoring And Diagnostic Devices And Equipment Global Market Report 2024
Fetal And Neonatal Monitoring Devices Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
